- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 461M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 475M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 519M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $615M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $453M |
| Dividends Paid | Q1 2025 · Mar 31, 2025 | $134M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $139M |
| Capex restated | Q1 2025 · Mar 31, 2025 | $143M |
| Capex | Q1 2025 · Mar 31, 2024 | $143M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $30M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.03B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.43B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $2.13B |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2025 | $4.95B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $5.16B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $6.27B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.88B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.1B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $14B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $14.21B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.87B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.57B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $18.95B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.37B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2025 | $1.06 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.85 |
| Eps Basic restated | Q1 2025 · Mar 31, 2025 | $1.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $261M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $238M |
| Rd Expense restated | Q1 2025 · Mar 31, 2025 | $362M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $351M |
| Net Income restated | Q1 2025 · Mar 31, 2025 | $503M |
| Net Income | Q1 2025 · Mar 31, 2024 | $438M |
| Operating Income restated | Q1 2025 · Mar 31, 2025 | $616M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $631M |
| Gross Profit restated | Q1 2025 · Mar 31, 2025 | $1.86B |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.86B |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2025 | $723M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $700M |
| Revenue | Q1 2025 · Mar 31, 2025 | $2.59B |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.56B |